IP Library Granted Patent US 7,879,557
Granted Patent B2
US 7,879,557 · App. 10/537,614 · Granted Feb 1, 2011

Isolated fluorescent protein from

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,879,557
App. No.
10/537,614
Granted
Feb 1, 2011
Kind
B2
Abstract

The invention relates to the nucleotide and amino acid sequences and to the activity and use of the fluorescent protein CGFP.

Claims (18)

1. An isolated nucleic acid molecule, selected from the group consisting of:

a) a nucleic acid molecule encoding a polypeptide having the amino acid sequence of SEQ ID NO: 2;

b) a nucleic acid molecule comprising the sequence of SEQ ID NO: 1;

c) a nucleic acid molecule which is at least 95% homologous to the full-length nucleic acid sequence SEQ ID NO: 1 and whose complementary strand hybridizes under stringent conditions with a nucleic acid molecule encoding the amino acid sequence of SEQ ID NO: 2 or with a nucleic acid molecule consisting of the nucleic acid sequence of SEQ ID NO: 1, and which encodes a fluorescent protein.

2. The isolated nucleic acid molecule according to claim 1 , wherein said nucleic acid molecule further comprises a functional promoter operably linked to its 5′ end.

3. A recombinant vector comprising the isolated nucleic acid molecule of claim 1 or claim 2 .

4. A host cell, which contains the vector according to claim 3 .

5. A method of determining whether a gene of interest, or fragment thereof, has been expressed comprising monitoring the fluorescence of a polypeptide encoded by a fusion gene and comparing it to the fluorescence when the gene or fragment is not expressed, wherein said fusion gene comprises the nucleic acid of claim 1 operably linked to said gene of interest, or fragment thereof.

6. The recombinant vector of claim 3 , wherein the vector is an expression vector.

7. The vector of claim 6 , wherein said vector comprises an inducible promoter.

8. A method of producing a fluorescent protein encoded by the nucleic acid of claim 1 in a host cell, wherein said host cell is a bacteria cell or a eukaryotic cell comprising the steps of:

(i) transforming said host cell with the expression vector of claim 6 , and

(ii) growing said host cell from step (i) under conditions that permit said fluorescent polypeptide to be produced in the transformed host cell of part (i).

9. An isolated nucleic acid molecule, selected from the group consisting of:

a) a nucleic acid molecule encoding a polypeptide having the amino acid sequence of SEQ ID NO: 2;

b) a nucleic acid molecule comprising the sequence of SEQ ID NO: 1;

c) a nucleic acid molecule which is at least 95% homologous to the full-length nucleic acid sequence SEQ ID NO:1 and whose complementary strand hybridizes under stringent conditions with a nucleic acid molecule encoding the amino acid sequence of SEQ ID NO: 2 or with a nucleic acid molecule consisting of the nucleic acid sequence of SEQ ID NO: 1, and which encodes a fluorescent protein having an excitation peak of about 475 nm and an emission peak of about 493 nm.

10. The method of claim 8 , further comprising isolating the fluorescent polypeptide.

Assignments (4)
CHANGE OF NAME Recorded Apr 12, 2013
From: BAYER SCHERING PHARMA AG
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 030202/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2013
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 029908/0437 →
MERGER Recorded Jan 12, 2010
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 023769/0122 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2006
From: GOLZ, STEFAN; MARKOVA, SVETLANA; BURAKOVA, LUDMILA; FRANK, LUDMILA; VYSOTSKI, EUGENE
To: BAYER HEALTHCARE AG
Reel/Frame 016999/0889 →